[SRNE] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 131.98%
YoY- 1,630.67%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 4,665 4,874 4,019 2,243 902 988 1,337 130.22%
PBT -16,137 -25,499 -12,724 14,031 -46,113 -20,027 -25,413 -26.14%
Tax -1,398 -1,696 -701 -195 -1,164 -1,637 1,186 -
NP -14,187 -23,064 -11,957 14,373 -44,949 -18,390 -23,476 -28.54%
Tax Rate - - - 1.39% - - - -
Total Cost 18,852 27,938 15,976 -12,130 45,851 19,378 24,813 -16.75%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -304.12 -473.20 -297.51 640.79 -4,983.26 -1,861.34 -1,755.87 -68.96%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.20 -0.45 -0.23 0.22 -0.97 -0.48 -0.62 -52.99%
EPS Diluted -0.20 -0.45 -0.23 0.22 -0.97 -0.48 -0.62 -52.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.